Revenue (Quarterly) Chart

View Revenue (Quarterly) for MIOFF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 90.76M
March 31, 2026 79.13M
December 31, 2025 97.59M
September 30, 2025 88.32M
June 30, 2025 94.26M
March 31, 2025 73.36M
December 31, 2024 93.99M
September 30, 2024 83.54M
June 30, 2024 83.54M
March 31, 2024 77.51M
December 31, 2023 92.04M
September 30, 2023 79.18M
June 30, 2023 89.89M
March 31, 2023 78.11M
December 31, 2022 90.73M
September 30, 2022 79.09M
June 30, 2022 91.13M
March 31, 2022 82.84M
December 31, 2021 104.32M
September 30, 2021 92.29M
June 30, 2021 96.62M
March 31, 2021 84.72M
December 31, 2020 100.60M
September 30, 2020 88.04M
June 30, 2020 74.80M
Date Value
March 31, 2020 71.81M
December 31, 2019 88.44M
September 30, 2019 87.66M
June 30, 2019 85.12M
March 31, 2019 71.60M
December 31, 2018 76.44M
September 30, 2018 75.88M
June 30, 2018 82.57M
March 31, 2018 70.11M
December 31, 2017 94.04M
September 30, 2017 71.04M
June 30, 2017 72.51M
March 31, 2017 60.74M
December 31, 2016 70.40M
September 30, 2016 70.41M
June 30, 2016 69.59M
March 31, 2016 58.25M
December 31, 2015 60.92M
September 30, 2015 56.51M
June 30, 2015 57.58M
March 31, 2015 51.05M
December 31, 2014 59.32M
September 30, 2014 60.25M
June 30, 2014 62.44M
March 31, 2014 56.43M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Kao Corp. 2.879B
Kosé Holdings Corp. 543.76M
euglena Co., Ltd. 83.52M
Rohto Pharmaceutical Co., Ltd. 574.97M
Mandom Corp. 116.45M